Najat Khan, PhD, unpacks realistic timelines for AI-based drugs to make clinical impact and her priorities for Recursion as incoming CEO.

Researchers at the Department of Mechanical Engineering, Seoul National University, have applied the principle of interlacing ...

Decades of research into the ramifications of chronic and/or extreme stress have shown that prolonged exposure leads to ...

Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...